Compile Data Set for Download or QSAR
maximum 50k data
Found 12 of ic50 data for polymerid = 1256
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557849(1-(3-((4-((3,4-dichlorophenyl)amino)-7-methoxyquin...)
Affinity DataIC50:  2.40nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557852(1-(3-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-me...)
Affinity DataIC50:  2.80nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557850(6-((1-acryloylpiperidin-4-yl)oxy)-4-((3,4-dichloro...)
Affinity DataIC50:  5.90nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557858(6-((1-acryloylpiperidin-4- yl)oxy)-4-((4-bromo-3- ...)
Affinity DataIC50:  15nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557851(1-(3-((4-((2,4-dichlorophenyl)amino)-7-methoxyquin...)
Affinity DataIC50:  16nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557846(1-(4-((4-((2,4-dichlorophenyl)amino)-7-methoxyquin...)
Affinity DataIC50:  48nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557861(6-((1-acryloylpiperidin-4- yl)oxy)-7-methoxy-4-((3...)
Affinity DataIC50:  190nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557860(6-((1-acryloylpiperidin-4- yl)oxy)-4-((4-chloro-3-...)
Affinity DataIC50:  250nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557848(1-(3-((4-((2,4-dichlorophenyl)amino)pyrido[3,4-d]p...)
Affinity DataIC50:  390nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557855(6-((1-acryloylpiperidin-4- yl)oxy)-4-((4-chloro-3-...)
Affinity DataIC50:  410nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557856(6-((1-acryloylpiperidin-4- yl)oxy)-4-((3-(hydroxy-...)
Affinity DataIC50:  2.60E+3nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Homo sapiens (Human))
Board Of Regents, The University Of Texas System

US Patent
LigandPNGBDBM557864(6-((1-acryloylpiperidin-4- yl)oxy)-7-methoxy-4-((1...)
Affinity DataIC50:  3.00E+3nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent